These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31205630)

  • 1. Final Height and Endocrine Complications in Patients with β-Thalassemia Intermedia: Our Experience in Non-Transfused Versus Infrequently Transfused Patients and Correlations with Liver Iron Content.
    Yassin MA; Soliman AT; De Sanctis V; Yassin KS; Abdulla MA
    Mediterr J Hematol Infect Dis; 2019; 11(1):e2019026. PubMed ID: 31205630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe Liver Iron Concentrations (LIC) in 24 Patients with β-Thalassemia Major: Correlations with Serum Ferritin, Liver Enzymes and Endocrine Complications.
    Kanbour I; Chandra P; Soliman A; De Sanctis V; Nashwan A; Abusamaan S; Moustafa A; Yassin MA
    Mediterr J Hematol Infect Dis; 2018; 10(1):e2018062. PubMed ID: 30416694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statural Growth and Prevalence of Endocrinopathies in Relation to Liver Iron Content (LIC) in Adult Patients with Beta Thalassemia Major (BTM) and Sickle Cell Disease (SCD).
    Yassin MA; Soliman AT; De Sanctis V; Abdula MAJ; Riaz LM; Ghori FF; Yousaf A; Nashwan AJ; Abusamaan S; Moustafa A; Kohla S; Soliman DS
    Acta Biomed; 2018 Feb; 89(2-S):33-40. PubMed ID: 29451227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Final adult height and endocrine complications in young adults with β-thalassemia major (TM) who received oral iron chelation (OIC) in comparison with those who did not use OIC.
    Soliman AT; Yassin MA; De Sanctis V
    Acta Biomed; 2018 Feb; 89(2-S):27-32. PubMed ID: 29451226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between liver iron concentration determined by R2-MRI, serum ferritin, and liver enzymes in patients with thalassemia intermedia.
    Al-Momen H; Jasim SK; Hassan QA; Ali HH
    Blood Res; 2018 Dec; 53(4):314-319. PubMed ID: 30588469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-thalassaemia intermedia: evaluation of endocrine and bone complications.
    Baldini M; Marcon A; Cassin R; Ulivieri FM; Spinelli D; Cappellini MD; Graziadei G
    Biomed Res Int; 2014; 2014():174581. PubMed ID: 25110660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-thalassemia.
    Galanello R; Origa R
    Orphanet J Rare Dis; 2010 May; 5():11. PubMed ID: 20492708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated liver iron concentration is a marker of increased morbidity in patients with β thalassemia intermedia.
    Musallam KM; Cappellini MD; Wood JC; Motta I; Graziadei G; Tamim H; Taher AT
    Haematologica; 2011 Nov; 96(11):1605-12. PubMed ID: 21791471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Iron Overload in Patients with Acute Leukemia and Myelodysplastic Syndrome on Hepatic and Endocrine functions.
    Yassin MA; Soliman A; De Sanctis V; Hmissi SM; Abdulla MAJ; Ekeibed Y; Ismail O; Nashwan A; Soliman D; Almusharaf M; Hussein R
    Acta Biomed; 2018 Apr; 89(3-S):18-22. PubMed ID: 29633728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-life experience with liver iron concentration R2 MRI measurement in patients with hemoglobinopathies: baseline data from LICNET.
    Vitrano A; Calvaruso G; Tesé L; Gioia F; Cassarà F; Campisi S; Butera F; Commendatore V; Rizzo M; Santoro V; Cigna V; Quota A; Bagnato S; Argento C; Fidone C; Schembari D; Gerardi C; Barbiera F; Bellisssima G; Giugno G; Polizzi G; Rosso R; Abbate G; Caruso V; Chiodi E; Gamberini MR; Giorgi B; Putti MC; Filosa A; De Ritis MR; Oliva E; Arcadi N; Fustaneo M; Mistretta L; Di Maggio R; Sacco M; Veronica DS; Giangreco A; Maggio A
    Eur J Haematol; 2016 Oct; 97(4):361-70. PubMed ID: 26818147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-Thalassemia Intermedia: A Single Thalassemia Center Experience from Northeastern Iraq.
    Amin SS; Jalal SD; Ali KM; Mohammed AI; Rasool LK; Osman TJ
    Biomed Res Int; 2020; 2020():2807120. PubMed ID: 32190657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Entity-Thalassemic Endocrine Disease: Major Beta-Thalassemia and Endocrine Involvement.
    Carsote M; Vasiliu C; Trandafir AI; Albu SE; Dumitrascu MC; Popa A; Mehedintu C; Petca RC; Petca A; Sandru F
    Diagnostics (Basel); 2022 Aug; 12(8):. PubMed ID: 36010271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An ICET- A survey on Hypoparathyroidism in Patients with Thalassaemia Major and Intermedia: A preliminary report.
    De Sanctis V; Soliman AT; Canatan D; Elsedfy H; Karimi M; Daar S; Rimawi H; Christou S; Skordis N; Tzoulis P; Sobti P; Kakkar S; Kilinc Y; Khater D; Alyaarubi SA; Kaleva V; Lum SH; Yassin MA; Saki F; Obiedat M; Anastasi S; Galati MC; Raiola G; Campisi S; Soliman N; Elshinawy M; Jaouni SA; Di Maio S; Wali Y; Elhakim IZ; Kattamis C
    Acta Biomed; 2018 Jan; 88(4):435-444. PubMed ID: 29350657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thalassemia Intermedia: Chelator or Not?
    Lee YC; Yen CT; Lee YL; Chen RJ
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron Overload in Patients With Heavily Transfused Sickle Cell Disease-Correlation of Serum Ferritin With Cardiac T2
    Alkindi S; Panjwani V; Al-Rahbi S; Al-Saidi K; Pathare AV
    Front Med (Lausanne); 2021; 8():731102. PubMed ID: 34760898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of endocrine complications in transfusion dependent thalassemia in Hospital Pulau Pinang: A pilot study.
    Lee KT; Lim SL; Goh AS
    Med J Malaysia; 2020 Jan; 75(1):33-37. PubMed ID: 32008017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thalassemia.
    Cohen AR; Galanello R; Pennell DJ; Cunningham MJ; Vichinsky E
    Hematology Am Soc Hematol Educ Program; 2004; ():14-34. PubMed ID: 15561674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired Hypogonadotropic Hypogonadism (AHH) in Thalassaemia Major Patients: An Underdiagnosed Condition?
    De Sanctis V; Elsedfy H; Soliman AT; Elhakim IZ; Pepe A; Kattamis C; Soliman NA; Elalaily R; El Kholy M; Yassin M
    Mediterr J Hematol Infect Dis; 2016; 8(1):e2016001. PubMed ID: 26740862
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.